Hospital Central Dr Ignacio Morones Prieto
San Luis Potosi, Mexico
General hospital in San Luis Potosí
Av. Venustiano Carranza S/N, Zona Universitaria, 78290 San Luis, S.L.P.
About Hospital Central Dr Ignacio Morones Prieto
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hospital Central Dr Ignacio Morones Prieto
During the past decade, Hospital Central Dr Ignacio Morones Prieto conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 18 clinical trials were completed, i.e. on
average, 78.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
2007-10-12
2024-12-01
Active, not recruiting
701
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2012-06-18
Unknown status
1,070
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
2009-07-15
2021-06-15
Completed
506
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
2010-02-15
2018-08-15
Completed
356
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
2011-04-01
2023-07-01
Active, not recruiting
1,545
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Central Dr Ignacio Morones Prieto" #1 sponsor was "Universidad Autonoma de San Luis Potosí" with 22 trials, followed by "Hospital Central "Dr. Ignacio Morones Prieto"" with 6 trials
sponsored, "Pfizer" with 5 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Genentech, Inc."
with 3 trials sponsored. Other sponsors include 17 different institutions and
companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Central Dr Ignacio Morones Prieto"
#1 collaborator was "Hospital Central "Dr. Ignacio Morones Prieto"" with 14 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Universidad Autonoma de San Luis Potosí" with 2 trials as a collaborator, "Basilea Pharmaceutica International Ltd" with 1 trials as a collaborator and "Bausch Health Americas, Inc." with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at Hospital Central Dr Ignacio Morones Prieto
According to Clinical.Site data, the most researched conditions in "Hospital Central Dr Ignacio Morones Prieto" are
"Melasma" (4 trials), "Head Injury" (3 trials), "Cardiovascular Disease" (2 trials), "Coronary Artery Disease" (2 trials) and "Juvenile Idiopathic Arthritis" (2 trials). Many other conditions were trialed in "Hospital Central Dr Ignacio Morones Prieto" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Central Dr Ignacio Morones Prieto
Most popular intervention types in "Hospital Central Dr Ignacio Morones Prieto" are "Drug" (46 trials), "Other" (7 trials), "Procedure" (5 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (20 trials), "Rosuvastatin" (4 trials), "placebo" (4 trials), "Atorvastatin" (2 trials) and "Etanercept" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Central Dr Ignacio Morones Prieto
The vast majority of trials in "Hospital Central Dr Ignacio Morones Prieto" are
52 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Hospital Central Dr Ignacio Morones Prieto
Currently, there are NaN active trials in "Hospital Central Dr Ignacio Morones Prieto".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 38 completed trials in Hospital Central Dr Ignacio Morones Prieto,
1 suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Central Dr Ignacio Morones Prieto, 1 "Phase 1"
clinical trials were conducted, 13 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 13 trials, and there were
also 4 trials that are defined as “Not Applicable".